Clinical trial
A Phase Ⅲ Trial to Compare Efficacy and Safety of Definitive Chemoradiation VS Neoadjuvant Chemoradiation Plus Surgery in Patients Who Achieved Clinical Complete Response After Neoadjuvant Treatment for Locally Advanced Esophageal Cancer
NCT03708042 is registered in ClinicalTrials.gov with Tianjin Medical University Cancer Institute and Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase Ⅲ Trial to Compare Efficacy and Safety of Definitive Chemoradiation VS Neoadjuvant Chemoradiation Plus Surgery in Patients Who Achieved Clinical Complete Response After Neoadjuvant Treatment for Locally Advanced Esophageal Cancer
- Lead sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- December 1, 2018
- Completion date
- December 1, 2023
- Enrollment
- 220 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
stage ii esophageal cancer, stage iii esophageal cancer